Warrant
Issued 2023
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
ONCY$0.3991-0.23%
Oncolytics Biotech Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$50.89M
Float & O/S:
Inst Own:
DilutionScan read 36 of ONCOLYTICS BIOTECH INC's SEC filings and found 3 warrant series, 4 ATM programs, 1 equity line and 3 shelf registrations on file for ONCY. The latest dilution event on file is ATM sales on Aug 10, 2026. Analysis updated Oct 4, 2026.
Signal8 Summary
ONCY
Going-concern warning from auditors
Snapshot
Oncolytics is a clinical-stage biotechnology company that currently generates no revenue and burns roughly $20M a year. The company holds only $5.1M in cash, which is not enough to fund operations for the next year, triggering a formal going-concern warning from auditors.
What's Happening Right Now
- : The FDA granted Fast Track designation to pelareorep in combination with a checkpoint inhibitor for second-line anal cancer, targeting a market with an estimated $1B annual opportunity where no approved therapies currently exist.
- : The company disclosed a going-concern warning in its Q1 2026 10-Q, stating its $5.5M cash position is insufficient to fund planned operations for the next twelve months without additional financing.
- : The company reported durable responses for pelareorep in second-line RAS-mutant MSS colorectal cancer, with a median duration of response of 19.5 months, a 3-4x improvement over historical benchmarks.
Raise routes on file: active ATM + effective shelf · latest dilution event 85 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Aug 10, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Outstanding
Warrant
Issued 2023
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
2023 Compensation Warrants (underwriter)
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
ATM program
Issued 2026
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
ATM program
Issued 2025
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
ATM program
Issued 2024
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
ATM program
Issued 2022
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
Equity line
Issued 2025
Commitment
Sold to date
Remaining
- Agreement date
- Term ends
- Discount
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
F-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
F-10 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Know who's about to sell into your ONCY trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
